29 results
8-K
EX-2.1
ODYY
Odyssey Health, Inc.
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
., the Emergency Planning and Community Right-to-Know Act, as amended, 42 U.S.C. § 11001 et seq., the Safe Drinking Water Act, as amended, 42 U.S.C. § 300(f
8-K
EX-10.1
y956voxr29ytkl
23 Nov 22
Entry into a Material Definitive Agreement
5:10pm
424B3
2x3vfvih2i51n
9 Aug 22
Prospectus supplement
9:26am
8-K
EX-99.1
nrwi1h 20bmm17
20 Apr 22
Regulation FD Disclosure
5:15pm
8-K
EX-99.1
a7wx4l
10 Jan 22
Regulation FD Disclosure
9:02am
8-K
EX-99.1
zmy b5jre2n
24 Sep 21
Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion
4:01pm
DEF 14A
xskaopjd5bre
6 Aug 21
Definitive proxy
4:02pm
PRER14A
dwk42z
28 May 21
Preliminary revised proxy
5:09pm
PRE 14A
pd3sa14a47 a4ey2
7 May 21
Preliminary proxy
5:27pm
8-K
EX-10.5
qbgyvtp gfvprwpxm8kt
8 Jan 21
Entry into a Material Definitive Agreement
5:21pm